» Articles » PMID: 18644985

WT1 Induction of Mitogen-activated Protein Kinase Phosphatase 3 Represents a Novel Mechanism of Growth Suppression

Overview
Journal Mol Cancer Res
Specialty Cell Biology
Date 2008 Jul 23
PMID 18644985
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

In its role as a tumor suppressor, WT1 transactivates several genes that are regulators of cell growth and differentiation pathways. For instance, WT1 induces the expression of the cell cycle regulator p21, the growth-regulating glycoprotein amphiregulin, the proapoptotic gene Bak, and the Ras/mitogen-activated protein kinase (MAPK) inhibitor Sprouty1. Here, we show that WT1 transactivates another important negative regulator of the Ras/MAPK pathway, MAPK phosphatase 3 (MKP3). In a WT1-inducible cell line that exhibits decreased cell growth and increased apoptosis on expression of WT1, microarray analysis showed that MKP3 is the most highly induced gene. This was confirmed by real-time PCR where MKP3 and other members of the fibroblast growth factor 8 syn expression group, which includes Sprouty 1 and the Ets family of transcription factors, were induced rapidly following WT1 expression. WT1 induction was associated with a block in the phosphorylation of extracellular signal-regulated kinase in response to epidermal growth factor stimulation, an effect mediated by MKP3. In the presence of a dominant-negative MKP3, WT1 could no longer block phosphorylation of extracellular signal-regulated kinase. Lastly, when MKP3 expression is down-regulated by short hairpin RNA, WT1 is less able to block Ras-mediated transformation of 3T3 cells.

Citing Articles

A systematic analysis of genetic interactions and their underlying biology in childhood cancer.

Daub J, Amini S, Kersjes D, Ma X, Jager N, Zhang J Commun Biol. 2021; 4(1):1139.

PMID: 34615983 PMC: 8494736. DOI: 10.1038/s42003-021-02647-4.


Wilms' tumor 1 () promotes ovarian cancer progression by regulating E-cadherin and ERK1/2 signaling.

Han Y, Song C, Zhang T, Zhou Q, Zhang X, Wang J Cell Cycle. 2020; 19(20):2662-2675.

PMID: 32892698 PMC: 7644158. DOI: 10.1080/15384101.2020.1817666.


Dysregulation of Dual-Specificity Phosphatases by Epstein-Barr Virus LMP1 and Its Impact on Lymphoblastoid Cell Line Survival.

Lin K, Lin S, Lin J, Lin P, Teng P, Wu H J Virol. 2019; 94(4).

PMID: 31776277 PMC: 6997745. DOI: 10.1128/JVI.01837-19.


Mechanisms of transcriptional regulation by WT1 (Wilms' tumour 1).

Toska E, Roberts S Biochem J. 2014; 461(1):15-32.

PMID: 24927120 PMC: 8887836. DOI: 10.1042/BJ20131587.


SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability.

Marshall G, Liu P, Gherardi S, Scarlett C, Bedalov A, Xu N PLoS Genet. 2011; 7(6):e1002135.

PMID: 21698133 PMC: 3116909. DOI: 10.1371/journal.pgen.1002135.


References
1.
Camps M, Chabert C, Muda M, Boschert U, Gillieron C, Arkinstall S . Induction of the mitogen-activated protein kinase phosphatase MKP3 by nerve growth factor in differentiating PC12. FEBS Lett. 1998; 425(2):271-6. DOI: 10.1016/s0014-5793(98)00250-6. View

2.
Maheswaran S, Park S, Bernard A, Morris J, Rauscher 3rd F, Hill D . Physical and functional interaction between WT1 and p53 proteins. Proc Natl Acad Sci U S A. 1993; 90(11):5100-4. PMC: 46662. DOI: 10.1073/pnas.90.11.5100. View

3.
Wagner N, Wagner K, Theres H, Englert C, Schedl A, Scholz H . Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1. Genes Dev. 2005; 19(21):2631-42. PMC: 1276736. DOI: 10.1101/gad.346405. View

4.
Morrison D, English M, Licht J . WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak. Cancer Res. 2005; 65(18):8174-82. DOI: 10.1158/0008-5472.CAN-04-3657. View

5.
Williams B . Identification of connective tissue growth factor as a target of WT1 transcriptional regulation. J Biol Chem. 2000; 275(49):38139-50. DOI: 10.1074/jbc.M004901200. View